VEGF-targeted magnetic nanoparticles for MRI visualization of brain tumor

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 11, Issue 4, 2015, Pages 825-833

  Abakumov, Maxim A ^a,c   Nukolova, Natalia V ^a,b,c   Sokolsky Papkov, Marina ^e   Shein, Sergey A ^b   Sandalova, Tatiana O ^b   Vishwasrao, Hemant M ^d,e   Grinenko, Nadezhda F ^e   Gubsky, Iliya L ^a   Abakumov, Artem M ^f   Kabanov, Alexander V ^c,e   Chekhonin, Vladimir P ^a,b  

^a PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^b Serbsky State Research Center of Forensic and Social Psychiatry   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^e UNC Hamner Institute for Drug Safety Sciences   (United States)

^f UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Glioblastoma; Iron oxide nanoparticles; MRI; VEGF

Indexed keywords

CELL DEATH; CELL ENGINEERING; DECOMPOSITION; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAGNETISM; MAGNETITE; MAMMALS; MONOCLONAL ANTIBODIES; SYNTHESIS (CHEMICAL); TUMORS; VISUALIZATION;

BOVINE SERUM ALBUMINS; COATED NANOPARTICLES; GLIOBLASTOMAS; IRON OXIDE NANOPARTICLE; SYNTHESIS AND CHARACTERIZATIONS; TARGETED NANOPARTICLE; VASCULAR ENDOTHELIAL GROWTH FACTOR; VEGF;

MAGNETIC NANOPARTICLES;

BOVINE SERUM ALBUMIN; FERRIC OXIDE; IRON OXIDE; MACROGOL; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; VASCULOTROPIN; CONTRAST MEDIUM; MAGNETITE NANOPARTICLE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; BRAIN TUMOR; CONJUGATION; CONTROLLED STUDY; CROSS LINKING; DECOMPOSITION; GLIOMA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA HALF LIFE; RAT; SYNTHESIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BOVINE; CHEMISTRY; METABOLISM; RADIOGRAPHY; WISTAR RAT;

BOVINAE;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; BRAIN NEOPLASMS; CATTLE; CONTRAST MEDIA; GLIOMA; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84929380237     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.12.011     Document Type: Article

References (27)

1. Rizvi S., Asghar A.H., Mehboob J. Gliosarcoma: A rare variant of glioblastoma multiforme. J Pak Med Assoc 2010, 9:773-775.
2. Giannopoulos S., Kyritsis A.P. Diagnosis and management of multifocal gliomas. Oncology 2010, 79:306-312.
3. 3 and Gd-DTPA and their influence on proton magnetic relaxation in rat tissues. Magn Reson Imaging 1987, 5:221-231.
4. ABLAVAR® [package insert] 2011, Lantheus Medical Imaging, Inc, North Billerica, MA.
5. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. Applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys 2003, 36:167-181.
6. Peng X., Qian X., Mao H., Wang A.Y., Chen Z.G., Nie S., et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int J Nanomedicine 2008, 3:311-321.
7. Santana S.D., Dhadge V.L., Roque A.C. Dextran-coated magnetic supports modified with a biomimetic ligand for IgG purification. ACS Appl Mater Interfaces 2012, 4:5907-5914.
8. Laurent S., Forge D., Port M., Roch A., Vander E.L., Muller R. Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008, 108:2064-2110.
9. Yu M., Huang S., Yu K.J., Clyne A.M. Dextran and polymer polyethylene glycol (PEG) coating reduce both 5 and 30 nm iron oxide nanoparticle cytotoxicity in 2D and 3D cell culture. Int J Mol Sci 2012, 13:5554-5570.
10. Ferguson R.M., Minard K.R., Krishnan K.M. Optimization of nanoparticle core size for magnetic particle imaging. J Magn Magn Mater 2009, 321:1548-1551.
11. Roohi F., Lohrke J., Ide A., Schütz G., Dassler K. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles. Int J Nanomedicine 2012, 7:4447-4458.
12. Wiogo H.T., Lim M., Bulmus V., Yun J., Amal R. Stabilization of magnetic iron oxide nanoparticles in biological media by fetal bovine serum (FBS). Langmuir 2011, 27:843-850.
13. Yang Q., Liang J., Han H. Probing the interaction of magnetic iron oxide nanoparticles with bovine serum albumin by spectroscopic techniques. J Phys Chem B 2009, 113:10454-10458.
14. Norden A.D., Drappatz J., Wen P.Y. Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 2009, 5:610-620.
15. Ancopoulos G.D., Davis S., Gale N.W., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248.
16. Plate K.H., Breier G., Weich H.A., Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992, 359:845-848.
17. Schneider S.W., Ludwig T., Tatenhorst L., Braune S., Oberleithner H., Senner V., et al. Acta Neuropathol 2004, 107:272-276.
18. Shein S.A., Gurina O.I., Leopol'd A.V., Baklaushev V.P., Korchagina A.A., Grinenko N.F., et al. Generation of monoclonal antibodies to recombinant vascular endothelial growth factor. Bull Exp Biol Med 2012, 153:139-142.
19. Hunter W.M., Greenwood F.C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962, 194:495-496.
20. Paul C.A., Beltz B., Berger-Sweeney J. Perfusion of brain tissues with fixative. Cold Spring Harb Protoc 2008, 3:1-4.
21. Chekhonin V.P., Baklaushev V.P., Yusubalieva G.M., Pavlov K.A., Ukhova O.V., Gurina O.I. Modeling and immunohistochemical analysis of C6 glioma in vivo. Bull Exp Biol Med 2007, 143:501-509.
22. Chen K., Xie J., Xu H., Behera D., Michalski M.H., Biswal S., et al. Triblock copolymer coated iron oxide nanoparticle conjugate for tumor integrin targeting. Biomaterials 2009, 30:6912-6919.
23. Ferrara N. Vascular Endothelial Growth Factor as a target for anticancer therapy. Oncologist 2004, 9:2-10.
24. Majumdar S., Zoghbi S.S., Gore J.C. Pharmacokinetics of superparamagnetic iron-oxide MR contrast agents in the rat. Investig Radiol 1990, 25:771-777.
25. Kratz F. Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles. J Control Release 2008, 132:171-183.
26. Amoozgar Z., Yeo Y. Recent advances in stealth coating of nanoparticle drug delivery systems. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2012, 4:219-233.
27. Schmidt N.O., Westphal M., Hagel C., Ergün S., Stavrou D., Rosen E.M., et al. evels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 1999, 84:10-18.